Office of Research & Development |
  |
Talk to the Veterans Crisis Line now
An official website of the United States government
Project Number: | I01CX002204-01 |
| Title: | The role of IL-17A in the onset and progression of diabetic retinopathy in VA patients |
| Principal Investigator: | Patricia Taylor |
| Location: | Cleveland, OH |
| Congressional District Code: | 11 |
| Research Service: | Clinical Science R&D |
| Project Period: | April 2021 - March 2025 |
| FY 2021 Funding Amount: | $155,500 |
| Total Award Amount (all years): |
$1,200,004 |
| Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Abstract Currently, 9% of the US population is diabetic, and an additional 86 million are being treated for pre-diabetes. Beyond this, one in every four Veteran receiving care from the VA is being treated for diabetes and its many physical complications, with more than half suffering from diabetic retinopathy. Making diabetic retinopathy a disease with a high healthcare burden in the Veteran population. Diabetic retinopathy is a microvascular disease of the retina, and is the leading cause of bl... |